Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-27T00:52:22.577Z Has data issue: false hasContentIssue false
  • English
  • Français

Dementia with Leukoencephalopathy in Systemic Lupus Erythematosus

Published online by Cambridge University Press:  18 September 2015

Andrew Kirk ,
Andrew Kertesz  and
Marsha J. Polk
Andrew Kirk*
Affiliation:
Department of Clinical Neurological Sciences, Lawson Research Institute, St. Joseph's Health Centre, University of Western Ontario, London
Andrew Kertesz
Affiliation:
Department of Clinical Neurological Sciences, Lawson Research Institute, St. Joseph's Health Centre, University of Western Ontario, London
Marsha J. Polk
Affiliation:
Department of Clinical Neurological Sciences, Lawson Research Institute, St. Joseph's Health Centre, University of Western Ontario, London
*
Department of Medicine (Neurology), Royal University Hospital, Saskatoon, Saskatchewan, Canada S7N 0X0
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Neurologic manifestations, afflicting up to 70% of SLE patients, include psychosis, seizures, chorea, neuropathies, and stroke. MRI is useful in evaluation of lupus patients and several reports have documented cerebral atrophy or focal hyperintensities. We report an unusual MRI appearance in a 56-year-old woman with SLE, diagnosed on the basis of pleuritis, lymphopenia, anti-DNA antibodies, and neurologic involvement. She reported recent onset of Raynaud's phenomenon and generalized macular rash. She presented after two months of gradual deterioration with memory loss, flattened affect, dysphagia, dysarthria, anomia, and somnolence, without focal neurologic signs. Investigations included elevated ESR, reduced complement, normal CSF without oligoclonal bands, negative viral serology, normal hormone and vitamin levels, normal renal and hepatic function. Neuropsychologic testing showed widespread impairment (WAIS-R: FSIQ-63; WMS-69; DRS-98; RCPM-14; WAB AQ-78.8). CT was normal but MRI showed strikingly symmetric, confluent hyperintensities extensively involving cerebral and cerebellar white matter on Tl and T2 weighted scans. Basal ganglia and subependymal and subcortical white matter were spared. Treated with prednisone, the patient made a gradual, but incomplete, recovery. These MRI findings may reflect widespread vasculopathy or direct immunologic brain insult with or without imunologic blood-brain barrier disruption.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 18 , Issue 3 , August 1991 , pp. 344 - 348
Copyright
Copyright © Canadian Neurological Sciences Federation 1991

References

REFERENCES

1.Dubois, EL, Tuffanelli, DL. Clinical manifestations of SLE: computer analysis of 520 cases. JAMA 1964; 190: 104–111.Google Scholar
2.Johnson, RT, Richardson, EP. The neurological manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature. Medicine 1968; 47: 337–369.CrossRefGoogle Scholar
3.McCune, WJ, Golbus, J. Neuropsychiatric lupus. Rheum Dis Clin North Am 1988; 14: 149–167.CrossRefGoogle ScholarPubMed
4.Devinsky, O, Petito, CK, Alonso, DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988; 23: 380–384.CrossRefGoogle ScholarPubMed
5.Bresnihan, B. CNS lupus. Clin Rheum Dis 1982; 8: 183–195.CrossRefGoogle ScholarPubMed
6.Kaell, AT, Shetty, M, Lee, BCP, et al. The diversity of neurologic events in systemic lupus erythematosus: prospective clinical and computed tomographic classification of 82 events in 71 patients. Arch Neurol 1986; 43: 273–276.CrossRefGoogle ScholarPubMed
7.Carbotte, RM, Denburg, SD, Denburg, JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986; 174: 357–364.CrossRefGoogle ScholarPubMed
8.Denburg, SD, Carbotte, RM, Denburg, JA. Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 1987; 9: 323–339.CrossRefGoogle ScholarPubMed
9.Sonies, BC, Klippel, JH, Gerber, RB, et al. Cognitive performance in systemic lupus erythematosus. Arthritis Rheum 1982; 25 (suppl): 580.Google Scholar
10.Levine, SR, Welch, KMA. The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulant and anticardiolipin antibodies. Arch Neurol 1987; 44: 876–883.CrossRefGoogle ScholarPubMed
11.Asherson, RA, Khamashta, MA, Gil, A, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J. Med 1989; 86: 391–399.CrossRefGoogle ScholarPubMed
12.Asherson, RA, Mercey, D, Phillips, G, et al. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 1987; 48: 605–611.CrossRefGoogle Scholar
13.Ellis, SG, Verity, MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 56 cases, 1955–1977. Semin Arthritis Rheum 1979; 8: 212–221.CrossRefGoogle Scholar
14.Bluestein, HG, Zvaifler, NJ. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest 1976; 57: 509–516.CrossRefGoogle ScholarPubMed
15.Bresnihan, B, Oliver, M, Grigor, R, et al. Brain-reactivity of lymphocytotoxic antibodies in SLE with and without cerebral involvement. Clin Exp Immunol 1977; 30: 333–337.Google Scholar
16.Bluestein, HG, Williams, GW, Steinberg, AD. Cerebrospinal fluid antibodies to neuronal cells; association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 1981; 70: 240–246.CrossRefGoogle ScholarPubMed
17.How, A, Dent, PB, Liao, S-K, et al. Antineuronal antibodies in neuropsychiatric lupus. Arthritis Rheum 1985; 28: 789–795.CrossRefGoogle Scholar
18.Denburg, JA, Carbotte, RM, Denburg, SD. Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 1987; 37: 464–467.CrossRefGoogle ScholarPubMed
19.Robbins, ML, Kornguth, SE, Bell, CL, et al. Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus:erythematosus: combination with anticardiolipin antibody assay and magnetic resonance imaging. Arthritis Rheum 1988; 31: 623–631.CrossRefGoogle ScholarPubMed
20.Bluestein, HG, Zvaifler, NJ. Antibodies reactive with central nervous system antigens. Hum Pathol 1983; 14: 424–428.CrossRefGoogle ScholarPubMed
21.Fields, RA, Sibbitt, WL, Toubbeh, , et al. Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies. Ann Rheum Dis 1990; 49: 114–117.CrossRefGoogle ScholarPubMed
22.Hogan, MJ, Brunet, DG, Ford, PM, et al. Lupus anticoagulant, antiphospholipid antibodies and migraine. Can J Neurol Sci 1988; 15: 420–425.CrossRefGoogle ScholarPubMed
23.Denburg, SD, Carbotte, RM, Long, AA, et al. Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus. Brain Behav Immunol 1988; 2: 222–234.CrossRefGoogle ScholarPubMed
24.Carette, S, Urowitz, MB, Grosman, H, et al. Cranial computerized tomography in systemic lupus erythematosus. J Rheumatol 1982; 9: 855–859.Google ScholarPubMed
25.Bilaniuk, LT, Patel, S, Zimmerman, RA. Central nervous system disease in systemic lupus erythematosus. Radiology 1977; 124: 119–121.CrossRefGoogle ScholarPubMed
26.Gonzalez-Scarano, F, Lisak, RP, Bilaniuk, LT, et al. Cranial computed tomography in the diagnosis of systemic lupus erythematosus. Ann Neurol 1979; 5: 158–165.CrossRefGoogle ScholarPubMed
27.Killian, PJ, Schnapf, DJ, Lawless OG. Computerized axial tomography of central nervous system lupus. Arthritis Rheum 1979; 22: 628–629.Google Scholar
28.Gaylis, N, Altman, RD, Ostrov, S, et al. The selective value of computer assisted tomography (CAT) of the brain in cerebritis due to systemic lupus erythematosus (SLE). Arthritis Rheum 1981; 24: s120.Google Scholar
29.Vermess, M, Bernstein, RM, Bydder, GM, et al. Nuclear magnetic resonance (NMR) imaging of the brain in systemic lupus erythematosus. J Comput Assist Tomogr 1983; 7: 461–467.CrossRefGoogle ScholarPubMed
30.Aisen, AM, Gabrielsen, TO, McCune, WJ. MR imaging of systemic lupus erythematosus involving the brain. Am J Neuroradiol 1985; 144: 1027–1031.Google ScholarPubMed
31.McCune, WJ, MacGuire, A, et al. Identification of brain lesions in neuropsychiatric system lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988; 31: 159–166.CrossRefGoogle Scholar
32.Sibbitt, WL, Sibbitt, RR, Griffey, RH, et al. Magnetic resonance and computed tomographic imaging in the evolution of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 1014–1022.CrossRefGoogle Scholar
33.Jacobs, L, Kinkel, PR, Costello , PB, et al. Central nervous system lupus erythematosus: the value of magnetic resonance imaging. J Rheumatol 1988; 15: 601–606.Google ScholarPubMed
34.Suzuki, K, Hara, M, Nakajima, S, et al. Analysis of systemic lupus erythematosus (SLE) involving the central nervous system by magnetic resonance imaging. Ryumachi 1989; 29: 88–96.Google ScholarPubMed
35.Sewell, KL, Livneh, A, Aranow, CB, et al. Magnetic resonance imaging versus computed tomographic scanning in neuropsychiatric systemic lupus erythematosus. Am J Med 1989; 86: 625–626.CrossRefGoogle ScholarPubMed
36.Tan, EM, Cohen, AS, Fries, JF, et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982; 25: 1271–1277.CrossRefGoogle Scholar
37.Lief, VF, Silverman, TPsychosis associated with lupus erythematosus disseminatus. Arch Gen Psychiatr 1960; 3: 608.CrossRefGoogle ScholarPubMed
38.Feinglass, EJ, Arnett, FC, Dorsch, CA, et al. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum and relationship to other features of the disease. Medicine 1976; 55: 323–339.CrossRefGoogle ScholarPubMed
39.Stern, M, Robbins, ES. Psychosis in systemic lupus erythematosus. Arch Gen Psych 1960; 3: 205–212.CrossRefGoogle ScholarPubMed